Balchem Co. (NASDAQ:BCPC) Shares Purchased by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. boosted its holdings in Balchem Co. (NASDAQ:BCPC) by 3.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 14,805 shares of the basic materials company’s stock after buying an additional 561 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Balchem were worth $2,202,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. The Manufacturers Life Insurance Company boosted its holdings in Balchem by 0.6% in the second quarter. The Manufacturers Life Insurance Company now owns 12,791 shares of the basic materials company’s stock valued at $1,724,000 after purchasing an additional 81 shares in the last quarter. Mercer Global Advisors Inc. ADV boosted its holdings in Balchem by 5.2% in the second quarter. Mercer Global Advisors Inc. ADV now owns 1,808 shares of the basic materials company’s stock valued at $244,000 after purchasing an additional 89 shares in the last quarter. First Republic Investment Management Inc. boosted its holdings in Balchem by 3.0% in the first quarter. First Republic Investment Management Inc. now owns 3,108 shares of the basic materials company’s stock valued at $393,000 after purchasing an additional 91 shares in the last quarter. Franklin Resources Inc. boosted its holdings in Balchem by 4.6% in the second quarter. Franklin Resources Inc. now owns 2,125 shares of the basic materials company’s stock valued at $276,000 after purchasing an additional 93 shares in the last quarter. Finally, SageView Advisory Group LLC boosted its holdings in Balchem by 2.1% in the third quarter. SageView Advisory Group LLC now owns 4,814 shares of the basic materials company’s stock valued at $597,000 after purchasing an additional 98 shares in the last quarter. 87.91% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Theodore L. Harris sold 34,350 shares of the stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $154.29, for a total value of $5,299,861.50. Following the completion of the sale, the chief executive officer now directly owns 66,412 shares of the company’s stock, valued at $10,246,707.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO William A. Backus sold 7,000 shares of the company’s stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $155.19, for a total transaction of $1,086,330.00. Following the completion of the sale, the chief accounting officer now owns 5,914 shares in the company, valued at $917,793.66. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Theodore L. Harris sold 34,350 shares of the company’s stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $154.29, for a total value of $5,299,861.50. Following the sale, the chief executive officer now owns 66,412 shares of the company’s stock, valued at approximately $10,246,707.48. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 76,630 shares of company stock valued at $11,843,249. 1.77% of the stock is currently owned by company insiders.

Balchem Price Performance

BCPC stock opened at $143.48 on Friday. The company has a market capitalization of $4.63 billion, a P/E ratio of 42.83, a PEG ratio of 4.34 and a beta of 0.71. Balchem Co. has a twelve month low of $110.74 and a twelve month high of $159.52. The business has a 50 day simple moving average of $152.39 and a 200-day simple moving average of $139.36. The company has a current ratio of 2.12, a quick ratio of 1.38 and a debt-to-equity ratio of 0.31.

Balchem (NASDAQ:BCPC) last posted its quarterly earnings data on Friday, February 16th. The basic materials company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.02. The business had revenue of $228.70 million during the quarter, compared to the consensus estimate of $234.66 million. Balchem had a return on equity of 10.69% and a net margin of 11.77%. The company’s revenue was down 1.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.66 earnings per share. As a group, equities analysts anticipate that Balchem Co. will post 4.14 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a report on Wednesday, February 21st.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.